SCHEMBL29674810

SCHEMBL29674810

CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 8/20 0.52
▸ FAAH O00519 6/20 0.47
▸ SLC6A5 Q9Y345 2/20 0.46
▸ PSMB5 P28074 1/20 0.44
▸ GLP1R P43220 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29674800 1.00 NOD1 (0.52) NOD1FAAHSLC6A5PSMB5GLP1R
SCHEMBL29429305 0.92 NOD1 (0.62) NOD1FAAHSLC6A5
SCHEMBL11283421 0.92 NOD1 (0.62) NOD1FAAHSLC6A5
SCHEMBL29429263 0.92 NOD1 (0.62) NOD1FAAHSLC6A5
SCHEMBL29429265 0.92 NOD1 (0.62) NOD1FAAHSLC6A5
SCHEMBL29675028 0.92 NOD1 (0.62) NOD1FAAHSLC6A5
SCHEMBL29429266 0.91 NOD1 (0.59) NOD1FAAHSLC6A5GLP1R
SCHEMBL29674818 0.90 NOD1 (0.63) NOD1FAAHSLC6A5PSMB5GLP1R
SCHEMBL29429322 0.90 NOD1 (0.63) NOD1FAAHSLC6A5PSMB5GLP1R
SCHEMBL29429315 0.90 NOD1 (0.63) NOD1FAAHSLC6A5PSMB5GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114846108-B Anti-pollution material 日产化学株式会社 2024-08-20 — — CN disclosed
US-20230404888-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER NISSAN CHEMICAL CORPORATION (JP) 2023-12-21 — — US disclosed
US-11771645-B2 Transdermally absorbable base material containing lipid peptide compound KYUSHU UNIVERSITY (JP) 2023-10-03 — — US disclosed
CN-116744892-A Compositions comprising a lipid peptide and a sucrose ester 日产化学株式会社 2023-09-12 — — CN disclosed
EP-4230265-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER Nissan Chemical Corporation (JP) 2023-08-23 — — EP disclosed
EP-3251656-B1 MOISTURIZING BASE MATERIAL INCLUDING LIPID-PEPTIDE COMPOUND UNIV KYUSHU (JP) 2023-07-05 — — EP disclosed
US-20230062111-A1 ANTI-POLLUTION MATERIAL NISSAN CHEMICAL CORPORATION (JP) 2023-03-02 — — US disclosed
EP-3881823-B1 SOLID BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND NISSAN CHEMICAL CORP (JP) 2023-01-25 — — EP disclosed
EP-4074380-A1 ANTI-POLLUTION MATERIAL Nissan Chemical Corporation (JP) 2022-10-19 — — EP disclosed
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound KYUSHU UNIVERSITY (JP) 2022-09-27 — — US disclosed
WO-2022168894-A1 CLOTH OR PAPER ANTI-POLLUTION MATERIAL 日産化学株式会社 2022-08-11 — — WO disclosed
CN-114846108-A Anti-pollution material 日产化学株式会社 2022-08-02 — — CN disclosed
EP-4014958-A1 COATING FILM-FORMING COMPOSITION Nissan Chemical Corporation (JP) 2022-06-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230404888-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER CUTA, SCAMP3, SURF4 NOD1 4669/4885FAAH 1817/4885SLC6A5 1995/4885
US-20230062111-A1 ANTI-POLLUTION MATERIAL PLIN3, CUTA, PLIN5 NOD1 4867/4885FAAH 2926/4885SLC6A5 4156/4885
US-11771645-B2 Transdermally absorbable base material containing lipid peptide compound NGLY1, NR1H4, HRH1 NOD1 2199/4885FAAH 8/4885SLC6A5 1157/4885
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound NGLY1, NR1H4, HRH1 NOD1 2199/4885FAAH 8/4885SLC6A5 1157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback